PUBLISHER: The Business Research Company | PRODUCT CODE: 1994603
PUBLISHER: The Business Research Company | PRODUCT CODE: 1994603
Gynecomastia treatment is a focused medical and surgical strategy aimed at diagnosing, managing, and correcting gynecomastia, a condition marked by benign enlargement of male breast tissue caused by hormonal imbalances, medications, or underlying health issues. The treatment seeks to reduce excess glandular or fatty tissue, restore a normal chest contour, relieve physical discomfort, and enhance psychological well-being through medical therapy, minimally invasive procedures, or surgical interventions.
The primary types of gynecomastia treatment include medications, surgical treatments, and alternative therapies. Medications refer to pharmaceutical interventions used to address hormonal imbalances or underlying causes of gynecomastia. These treatments are applied across age groups including adolescents, adults, and middle-aged and older populations. Distribution occurs via direct sales, distributor sales, and online platforms, and end users include hospitals, aesthetic clinics, ambulatory surgical centers, and endocrinology clinics.
Tariffs are influencing the gynecomastia treatment market by increasing costs of imported surgical instruments, liposuction devices, hormone therapy drugs, and medical consumables used in treatment procedures. Healthcare providers in North America and Europe are most affected due to reliance on imported medical equipment and pharmaceuticals, while Asia-Pacific faces cost pressures in device manufacturing and distribution. These tariffs are contributing to higher treatment costs and influencing service pricing. At the same time, they are supporting domestic medical device production, regional pharmaceutical manufacturing, and innovation in cost-effective treatment solutions.
The gynecomastia treatment market research report is one of a series of new reports from The Business Research Company that provides gynecomastia treatment market statistics, including gynecomastia treatment industry global market size, regional shares, competitors with a gynecomastia treatment market share, detailed gynecomastia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the gynecomastia treatment industry. This gynecomastia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The gynecomastia treatment market size has grown strongly in recent years. It will grow from $2.98 billion in 2025 to $3.23 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increasing diagnosis rates of gynecomastia, growing awareness of male health conditions, availability of advanced surgical procedures, expansion of aesthetic medicine services, rising acceptance of corrective treatments.
The gynecomastia treatment market size is expected to see strong growth in the next few years. It will grow to $4.49 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing demand for personalized treatment plans, rising adoption of advanced liposuction technologies, expansion of outpatient surgical facilities, growing focus on psychological well-being, increasing investment in male health services. Major trends in the forecast period include increasing adoption of minimally invasive surgical techniques, rising demand for hormone-based medical therapies, growing preference for combined treatment approaches, expansion of specialized aesthetic clinics, enhanced focus on patient counseling and post-treatment care.
The increasing acceptance of male aesthetic and cosmetic procedures is expected to stimulate the growth of the gynecomastia treatment market in the future. Male aesthetic and cosmetic procedures include medical and surgical treatments aimed at enhancing physical appearance, addressing areas such as body contouring, facial aesthetics, skin quality, and hair restoration. Acceptance of these procedures is rising due to evolving societal attitudes toward male grooming and body image, influenced by media exposure and increased awareness of aesthetic treatment options. Greater participation in male aesthetic and cosmetic procedures has encouraged men to seek gynecomastia treatment to achieve a firmer and more masculine chest profile. For example, in June 2024, according to the American Society of Plastic Surgeons (ASPS), a US-based professional organization, men accounted for 6% of all cosmetic procedures performed in 2023, with male body-focused procedures increasing by 18% and face and neck procedures rising by 15% compared to the previous year. Therefore, the increasing acceptance of male aesthetic and cosmetic procedures is supporting the growth of the gynecomastia treatment market.
The rising healthcare expenditure is expected to propel the growth of the gynecomastia treatment market going forward. Healthcare expenditure refers to the total financial resources spent on medical services, preventive care, medications, infrastructure, and related health activities to maintain or improve population health. Healthcare expenditure is increasing due to the rising prevalence of chronic and infectious diseases, which fuels sustained demand for long-term care, advanced therapies, and continuous medical services. Higher healthcare spending improves affordability and accessibility of elective procedures, enabling more men to pursue gynecomastia treatment to enhance chest appearance. For example, in April 2025, according to the Office for National Statistics, a UK-based government organization, overall healthcare spending rose by 6.5% from 2023 to 2024, marking faster growth compared with 2023 levels. Therefore, the rising healthcare expenditure is driving the growth of the gynecomastia treatment market.
In December 2024, Lorena Cosmetics Holdings SPV Limited, a UK-based healthcare services company, acquired the Harley Medical Group for an undisclosed amount. Through this acquisition, Lorena Cosmetics aimed to revitalize and consolidate an established cosmetic surgery brand, expand its presence within the UK aesthetic and surgical services sector, and strengthen its vertically integrated healthcare portfolio following the company's administration process. The Harley Medical Group is a UK-based provider specializing in cosmetic procedures including gynecomastia surgery.
Major companies operating in the gynecomastia treatment market are Spire Healthcare Group Plc, Max Healthcare Institute, InMode Ltd., Cynosure Inc., Pristyn Care Private Limited, Sterling Hospital, Paras Hospital, Prettislim Clinic, Allure Medspa, Lux Hospitals, Florida Plastic Surgery Group, Dermawear, DermaVue, AK Clinics Pvt. Ltd., BioZen, Medifyhome, PinkApple Aesthetics, The Aesthetica, Austin Gynecomastia Center, and Carely Clinic.
North America was the largest region in the gynecomastia treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gynecomastia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the gynecomastia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The gynecomastia treatment market consists of revenues earned by entities by providing services such as surgical evaluation and procedures, post-operative care and follow-up, counseling on lifestyle modifications, and non-surgical management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gynecomastia treatment market also includes sales of liposuction devices, hormone therapy drugs, topical treatments, and other supportive medical devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Gynecomastia Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses gynecomastia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for gynecomastia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gynecomastia treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.